Nj State Employees Deferred Compensation Plan Ionis Pharmaceuticals Inc Transaction History
Nj State Employees Deferred Compensation Plan
- $877 Million
- Q3 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 42,000 shares of IONS stock, worth $3.09 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
42,000
Previous 42,000
-0.0%
Holding current value
$3.09 Million
Previous $1.66 Million
65.58%
% of portfolio
0.31%
Previous 0.2%
Shares
7 transactions
Others Institutions Holding IONS
# of Institutions
445Shares Held
148MCall Options Held
1.72MPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.21 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$1.18 Billion0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$922 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$759 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$578 Million7.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $10.4B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...